Cargando…

Feasibility of biology-guided radiotherapy for metastatic renal cell carcinoma driven by PSMA PET imaging

BACKGROUND: Biology-guided radiotherapy (BgRT) is a novel treatment where the detection of positron emission originating from a volume called the biological tracking zone (BTZ) initiates dose delivery. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is a novel imaging te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaudreault, Mathieu, Chang, David, Hardcastle, Nicholas, McIntosh, Lachlan, Jackson, Price, Kron, Tomas, Udovicich, Cristian, Hofman, Michael S., Siva, Shankar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023908/ https://www.ncbi.nlm.nih.gov/pubmed/36942088 http://dx.doi.org/10.1016/j.ctro.2023.100608

Ejemplares similares

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Automated assessment of functional lung imaging with (68)Ga-ventilation/perfusion PET/CT using iterative histogram analysis
por: McIntosh, Lachlan, et al.
Publicado: (2021)

Assessing organ at risk position variation and its impact on delivered dose in kidney SABR
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

On the reduction of aperture complexity in kidney SABR
por: Gaudreault, Mathieu, et al.
Publicado: (2021)

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT
por: Jackson, Price, et al.
Publicado: (2014)

Treatment Time Optimization in Single Fraction Stereotactic Ablative Radiation Therapy: A 10-Year Institutional Experience
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy
por: Hardcastle, Nicholas, et al.
Publicado: (2019)

Out-of-field dose in stereotactic radiotherapy for paediatric patients
por: Garrett, Lachlan, et al.
Publicado: (2021)

Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer
por: Bucknell, Nicholas, et al.
Publicado: (2020)

A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
por: Siva, Shankar, et al.
Publicado: (2014)

A future of automated image contouring with machine learning in radiation therapy
por: Jackson, Price, et al.
Publicado: (2019)

(68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
por: Udovicich, Cristian, et al.
Publicado: (2017)

Deep Learning Renal Segmentation for Fully Automated Radiation Dose Estimation in Unsealed Source Therapy
por: Jackson, Price, et al.
Publicado: (2018)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer
por: Hardcastle, Nicholas, et al.
Publicado: (2021)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Dose to medium in head and neck radiotherapy: Clinical implications for target volume metrics
por: Hardcastle, Nicholas, et al.
Publicado: (2019)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Independent review of 4DCT scans used for SABR treatment planning
por: Antony, Rachitha, et al.
Publicado: (2020)

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT
por: Karagiannis, Vasileios, et al.
Publicado: (2022)

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
por: Henkenberens, Christoph, et al.
Publicado: (2021)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
por: Champion, Ambroise, et al.
Publicado: (2023)

Systematic endobronchial ultrasound-guided transbronchial needle aspiration improves radiotherapy planning in non-small cell lung cancer
por: Cole, Aidan Joseph, et al.
Publicado: (2019)

SABR for Synchronous Bilateral Primary Renal Cell Carcinoma: A Case Report
por: Ali, Muhammad, et al.
Publicado: (2022)

Re: The role of (68)Ga-PSMA-PET/CT in radiotherapy planning in prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2019)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography
por: Bucknell, Nicholas, et al.
Publicado: (2023)

A retrospective analysis of setup and intrafraction positional variation in stereotactic radiotherapy treatments
por: Barnes, Micah, et al.
Publicado: (2020)

Monitoring DNA Damage and Repair in Peripheral Blood Mononuclear Cells of Lung Cancer Radiotherapy Patients
por: Lobachevsky, Pavel N., et al.
Publicado: (2020)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

All that Glitters on PSMA is Not a Lesion: An Unusual Artifact on PSMA PET/CT
por: Dev, Indraja D., et al.
Publicado: (2021)

Dose-reduced [(18)F]PSMA-1007 PET is feasible for functional imaging of the renal cortex
por: Valind, Kristian, et al.
Publicado: (2021)

An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy
por: Siva, Shankar, et al.
Publicado: (2013)

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?
por: Alipour, Ramin, et al.
Publicado: (2019)

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
por: Hardcastle, Nicholas, et al.
Publicado: (2023)

Ga-68-PSMA PET/CT ? or PET/MRI ?, Mp-MRI ? in diagnosis and radiotherapy planning in a patient with prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2020)

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Pelvic salvage (SBRT) radiotherapy based on (68)Ga-PSMA PET/CT: About a case
por: Slaoui, A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jgu1konadeqm1r1pcn1shipjuo